No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

NCT07115810 · clinicaltrials.gov ↗

COMPLETED

Status

178

Enrollment

OTHER

Sponsor class

Conditions

Differentiated Thyroid Cancer

Interventions

OTHER: No additional drugs(control Group)

Sponsor

King Faisal Specialist Hospital & Research Center